12-132618825-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_170682.4(P2RX2):​c.9C>T​(p.Ala3=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00458 in 1,283,212 control chromosomes in the GnomAD database, including 238 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 139 hom., cov: 29)
Exomes 𝑓: 0.0021 ( 99 hom. )

Consequence

P2RX2
NM_170682.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.60
Variant links:
Genes affected
P2RX2 (HGNC:15459): (purinergic receptor P2X 2) The product of this gene belongs to the family of purinoceptors for ATP. This receptor functions as a ligand-gated ion channel. Binding to ATP mediates synaptic transmission between neurons and from neurons to smooth muscle. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Aug 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 12-132618825-C-T is Benign according to our data. Variant chr12-132618825-C-T is described in ClinVar as [Benign]. Clinvar id is 226991.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.6 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0762 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
P2RX2NM_170682.4 linkuse as main transcriptc.9C>T p.Ala3= synonymous_variant 1/11 ENST00000643471.2 NP_733782.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
P2RX2ENST00000643471.2 linkuse as main transcriptc.9C>T p.Ala3= synonymous_variant 1/11 NM_170682.4 ENSP00000494644 A2Q9UBL9-1

Frequencies

GnomAD3 genomes
AF:
0.0229
AC:
3453
AN:
150650
Hom.:
138
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.0786
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00923
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00955
Gnomad NFE
AF:
0.000356
Gnomad OTH
AF:
0.0213
GnomAD3 exomes
AF:
0.00687
AC:
261
AN:
38008
Hom.:
11
AF XY:
0.00612
AC XY:
128
AN XY:
20898
show subpopulations
Gnomad AFR exome
AF:
0.101
Gnomad AMR exome
AF:
0.00862
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000302
Gnomad OTH exome
AF:
0.00187
GnomAD4 exome
AF:
0.00214
AC:
2419
AN:
1132454
Hom.:
99
Cov.:
31
AF XY:
0.00197
AC XY:
1074
AN XY:
545630
show subpopulations
Gnomad4 AFR exome
AF:
0.0813
Gnomad4 AMR exome
AF:
0.00608
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000965
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000200
Gnomad4 OTH exome
AF:
0.00498
GnomAD4 genome
AF:
0.0229
AC:
3456
AN:
150758
Hom.:
139
Cov.:
29
AF XY:
0.0220
AC XY:
1623
AN XY:
73648
show subpopulations
Gnomad4 AFR
AF:
0.0784
Gnomad4 AMR
AF:
0.00922
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000356
Gnomad4 OTH
AF:
0.0210
Alfa
AF:
0.0127
Hom.:
7
Bravo
AF:
0.0252

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 24, 2014Ala3Ala in exon 1 of P2RX2: This variant is not expected to have clinical signif icance because it does not alter an amino acid residue and is not located within the splice consensus sequence. It has been identified in 6.6% (223/3356) of Afr ican American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs186684886). -
Benign, criteria provided, single submitterclinical testingGeneDxOct 05, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 22, 2024- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
4.4
DANN
Benign
0.96

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs186684886; hg19: chr12-133195411; API